✦ LIBER ✦

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 3/3 nonexpressors

✍ Scribed by Jian Wang; Adriana Zeevi; Kenneth McCurry; Erin Schuetz; HongXia Zheng; Aldo Iacono; Kevin McDade; Diana Zaldonis; Steven Webber; Richard M. Watanabe; Gilbert J. Burckart

Book ID: 116939991
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 105 KB
Volume: 15
Category: Article
ISSN: 0966-3274
DOI: 10.1016/j.trim.2005.08.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of CYP3A5 and MDR1(ABCB1) C3435T

Impact of CYP3A5 and MDR1(ABCB1) C3435T Polymorphisms on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients

✍ H. Tada; N. Tsuchiya; S. Satoh; H. Kagaya; Z. Li; K. Sato; M. Miura; T. Suzuki; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Tacrolimus Dosing in Pediatric Heart Tra

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

✍ HongXia Zheng; Steven Webber; Adriana Zeevi; Erin Schuetz; Jiong Zhang; Pamela B 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Influence of CYP3A5 and MDR1(ABCB1) Poly

Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients

✍ G. Rong; L. Jing; L. Deng-Qing; Z. Hong-Shan; Z. Shai-Hong; N. Xin-Min 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 381 KB

436 Effect of CYP3A5, CYP3A5 and ABCB1 G

436 Effect of CYP3A5, CYP3A5 and ABCB1 Genotypes in Tacrolimus Dose and Clinical Outcomes after Heart Transplantation

✍ B. Tavira; B. Díaz-Molina; J.L. Lambert; M.J. Bernardo; C. Morís; V. Álvarez; C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Population pharmacokinetics of tacrolimu

Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients

✍ D. Li; W. Lu; J.-Y. Zhu; J. Gao; Y.-Q. Lou; G.-L. Zhang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

CYP3A5 and ABCB1 polymorphisms in donor

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation

✍ Glowacki, F.; Lionet, A.; Buob, D.; Labalette, M.; Allorge, D.; Provot, F.; Hazz 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 189 KB

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 nonexpressors

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 3/3 nonexpressors